Astec Lifesciences approved the allotment of 2,669,951 equity shares at ₹890 each during the Rights Issue which opened on July 14, 2025, and closed on July 28, 2025, leading to an increase in paid-up capital from ₹196,117,100 to ₹222,816,610 on July 29, 2025.